24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

P05.062<br />

Duplication <strong>of</strong> exons 1 to 22 <strong>of</strong> the F gene: a new mechanism<br />

related to multiple copies <strong>of</strong> the intron 22 int22h sequence?<br />

C. Costa 1,2 , E. Bieth 3 , P. Boisseau 4 , S. Letourneau 1 , F. Dastot 1,2 , E. Girodon-<br />

Boulandet 1,2 , M. Goossens 1,2 ;<br />

1 AP-HP, Groupe Henri Mondor-Albert Chenevier, Laboratoire de Génétique Moléculaire,<br />

Créteil, France, 2 INSERM U841, Département de Génétique, équipe<br />

11, Université Paris 12, Créteil, France, 3 Hôpital Purpan, Laboratoire de Génétique<br />

Médicale, Toulouse, France, 4 CHU Hotel Dieu, Service de Génétique<br />

Médicale, Laboratoire de Génétique Moléculaire, Nantes, France.<br />

Interspersed repeats account for 56% <strong>of</strong> the euchromatic X chromosome<br />

sequence, compared with a genome average <strong>of</strong> 45% . Intrachromosomal<br />

duplications are estimated to account for 2 .59% <strong>of</strong> the X<br />

chromosome while interchromosomal duplications account for a very<br />

small fraction 0 .24% <strong>of</strong> the X chromosome . Among these duplications<br />

are well-described cases that are associated with genomic disorders .<br />

Some disorders may result from rearrangements involving duplicated<br />

sequences in Xq28, such as in haemophilia A . In severe haemophilia A,<br />

mutations are frequently the results <strong>of</strong> inversions between a sequence<br />

in intron 22 (int22h-1) <strong>of</strong> the F8 gene and one <strong>of</strong> two more distally<br />

located copies (int22h-2, int22h-3) described to be in the same orientation.<br />

Recently a novel finding from analysis <strong>of</strong> the DNA sequence<br />

<strong>of</strong> the human X chromosome (Ross et al, Nature 2005) has revealed<br />

that the two distal copies are in opposite orientations . Recombination<br />

should then produce deletion or duplication rather than inversion . A<br />

deletion consistent with this prediction has been reported in a family<br />

in which carrier females are affected by a high spontaneous-abortion<br />

rate in pregnancy. We report here the first case <strong>of</strong> duplication <strong>of</strong> exons<br />

1 to 22 in a carrier female in a family were none haemophiliac patient<br />

was available . The duplication was detected by MP-LC (Multiplex Liquid<br />

chromatography) and confirmed by MLPA. We believe this new<br />

rearrangement could be linked to the multiple copies <strong>of</strong> the intron 22<br />

sequences and would confirm the hypothesis that recombination could<br />

produce duplication .<br />

P05.063<br />

A comparison <strong>of</strong> quantitative real time PcR (Q-Rt-PcR) and<br />

Multiple Ligation-Dependent Probe Amplification (MLPA) for<br />

molecular diagnosis <strong>of</strong> deletions in cases <strong>of</strong> severe haemophilia<br />

A<br />

A. Venceslá, M. Baena, M. J. Barceló, J. Juan, L. Alias, M. Cornet, M.<br />

Domenech, P. Gallano, M. Baiget, E. F. Tizzano;<br />

Hospital Sant Pau, <strong>Barcelona</strong>, Spain.<br />

Haemophilia A (HA) is an X-linked bleeding disorder caused by mutations<br />

in coagulation factor VIII. The identification <strong>of</strong> HA carriers is an<br />

essential part <strong>of</strong> genetic counselling . Large rearrangements frequently<br />

occur within the F8 gene in severe haemophiliacs . These include the<br />

intron22 inversion (40-45%) the intron1 inversion (2-5%) and gross<br />

deletions encompassing one or more exons (5-10%) . Although gross<br />

deletions are readily detectable in males, the identification <strong>of</strong> heterozygosity<br />

in possible carriers <strong>of</strong> these families constitutes a challenge .<br />

To identify a deleted allele over the background <strong>of</strong> the normal allele in<br />

these carriers, we previously set up a Q-RT-PCR method employing<br />

LightCycler technology . A comparison was performed with the recently<br />

described MLPA P178 FVIII probemix that contains probes for each<br />

<strong>of</strong> the 26 exons <strong>of</strong> the F8 gene . We studied patients with deletions in<br />

exon 13, in exons 23-25, in exon 15 and in exons 1-22 . Carrier and<br />

non-carrier females from these families previously defined by quantitative<br />

or marker analysis were also tested . MLPA results in HA patients<br />

revealed the absence <strong>of</strong> the peak in the corresponding exon(s) . There<br />

was a complete correlation with results in the carrier group (one copy<br />

<strong>of</strong> the corresponding exon(s) by Q-RT-PCR and 40- 55% <strong>of</strong> reduced<br />

relative peak area in MLPA) and also in the non carrier group (two<br />

copies and 85-100% <strong>of</strong> peak area) . MLPA may be incorporated into<br />

routine molecular diagnosis <strong>of</strong> severe HA after screening <strong>of</strong> inversions .<br />

Supported by Fundació Catalana d´Hem<strong>of</strong>ilia, CIBERER, Real Fundación<br />

Victoria Eugenia.<br />

P05.064<br />

investigation <strong>of</strong> human mitochondrial DNA in iranian<br />

Hypertrophic cardiomyopathy (Hcm) patients<br />

M. Montazeri 1 , M. Houshmand 1 , E. V. Zaklyazminskaya 2 ;<br />

1 NRCGEB, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Russian Research Center <strong>of</strong><br />

Medical <strong>Genetics</strong> Laboratory <strong>of</strong> DNA Research, Mosque, Russian Federation.<br />

Mitochondrial (mt) DNA defects, both deletions and tRNA point mutations,<br />

have been associated with cardiomyopathies . The aim <strong>of</strong> the<br />

study was to determine the mtDNA mutations in Hypertrophic cardiomyopathy<br />

(HCM) Iranian patients.<br />

Hypertrophic cardiomyopathy (HCM) is widely accepted as a pluricausal<br />

or multifactorial disease . Because <strong>of</strong> the linkage between energy<br />

metabolism in the mitochondria and cardiac muscle contraction,<br />

it is reasonable to assume that mitochondrial abnormalities may be<br />

responsible for some forms <strong>of</strong> HCM . We analysed the whole mitochondrial<br />

genome in a series <strong>of</strong> 31 patients with HCM for alterations<br />

and compared the findings with those <strong>of</strong> 30 control subjects. A total <strong>of</strong><br />

X sequence changes could be identified. These sequence changes<br />

were distributed among the whole mitochondrial DNA (mtDNA) . An increased<br />

number <strong>of</strong> novel missense mutations could be detected nearly<br />

in all genes encoding for protein subunits in HCM patients subjects .<br />

Four mutations were found that are unpublished . The c .4384T>C in<br />

tRNA glutamin , c .9063A>G in AtPase6 , c .2071 T>C, c .3170C>A,<br />

in noncoding MTRNA2 16S . Also 33 polymorphisms were identified<br />

in this study which had not been published in the MitoMap database .<br />

The c .16189T>C mutation in the D-loop region that is associated with<br />

susceptibility to DCM could be detected in 3% <strong>of</strong> patients as well as in<br />

0% <strong>of</strong> controls . Furthermore, mtDNA mutations may play an important<br />

role in pathogenesis <strong>of</strong> cardiac arrest which has remained unexplained<br />

for long .<br />

P05.065<br />

investigation <strong>of</strong> 69 common mutations in MYH gene in iranian<br />

population with hypertrophic cardiomyopathy<br />

M. Montazeri1 , M. Houshmand1 , M. Ghani Kakhki1 , G. Estahbanati2 , M. M.<br />

Peyghambari3 , E. V. Zaklyazminskaya4 ;<br />

1 2 nrcgeb, Tehran, Islamic Republic <strong>of</strong> Iran, Iran University <strong>of</strong> Medical Sciences<br />

Shaheed Rajaie Cardiovascular Medical Center, Tehran, Iran, Tehran, Islamic<br />

Republic <strong>of</strong> Iran, 3Iran University <strong>of</strong> Medical Sciences Shaheed Rajaie Cardiovascular<br />

Medical Center, Tehran, Iran., Tehran, Islamic Republic <strong>of</strong> Iran,<br />

4Russian Research Center <strong>of</strong> Medical <strong>Genetics</strong> Laboratory <strong>of</strong> DNA Research,<br />

Moscow, Russia., Moscow, Russian Federation.<br />

Hypertrophic cardiomyopathy is characterized by hypertrophy <strong>of</strong><br />

ventricles and intrventricular septum . Patients could develop serious<br />

complications including heart failure, arrhythmias and sudden death .<br />

Familial hypertrophic cardiomyopathy is a single gene disorder and<br />

has autosomal dominant inheritance . In this study we focused on<br />

exons 13-15 and 19-21 <strong>of</strong> MYH7 gene and introns located between<br />

them, which contain hotspots for so called “malignant mutations” that<br />

increase sudden cardiac death risk . Methods: Fifty unrelated Iranian<br />

patients with hypertrophic cardiomyopathy were selected sequentially<br />

and informed written consent was obtained from them . Exons 13-15<br />

and 19-21 <strong>of</strong> MYH7 gene and their related introns were amplified by<br />

polymerase chain reaction . Then PCR products were sequenced . Results:<br />

Mutations were detected in fourteen (28%) <strong>of</strong> the patients . We<br />

didn’t find any malignant mutation, but three mutations were found in<br />

targeted exons . One <strong>of</strong> them, A10419C (N444T) in exon 14, may be<br />

a novel mutation .<br />

P05.066<br />

A novel mitochondrial DNA tRNAile (m.4322dupc) mutation<br />

associated with idiopathic dilated cardiomyopathy<br />

S. Mahjoub 1 , D. Sternberg 2 , R. Boussaada 3 , S. Filaut 2 , F. Guemira 4 , R. Mechmech<br />

3 , C. Jardel 2 , S. Ben Arab 1 ;<br />

1 Faculté de Médecine de Tunis, Tunis, Tunisia, 2 Fédération de génétique-UF<br />

Cardio et Myogénétique , Hôpital Pitié-salpétrière, Paris, France, 3 Hôpital La<br />

Rabta, Tunis, Tunisia, 4 Hôpital Salah Azaiez, Tunis, Tunisia.<br />

Dilated cardiomyopathy (DCM) is a heart muscle disease characterized<br />

by cardiac dilatation and impaired contraction <strong>of</strong> the left ventricle<br />

(LV) or both ventricles . The age at disease onset is highly variable,<br />

ranging from early childhood to late adulthood . Only 50% <strong>of</strong> patients<br />

with DCM survive >5 years after diagnosis . Approximately 20% to 25%<br />

<strong>of</strong> cases seem to have a genetic component . DCM can be transmit-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!